Status:
NOT_YET_RECRUITING
Cardiovascular Complications in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
INSERM UMR-S 942 MASCOT
INSERM U1086 Cancers et Préventions
Conditions:
Cardiotoxicity
DPP3
Eligibility:
All Genders
15+ years
Brief Summary
Allogeneic hematopoietic stem cell transplantation (HSCT) represents a major therapeutic strategy for malignant hematologic diseases, with the number of procedures steadily increasing in France each y...
Eligibility Criteria
Inclusion
- Age ≥ 15 years
- Informed about the study and without objection to participation (or with consent from legal guardians)
- Undergoing allogeneic HSCT
Exclusion
- Patient not followed up at the participating center
- Pregnant or breastfeeding women
- Patient not affiliated with social security
- Patient under guardianship, curatorship, or legal protection
Key Trial Info
Start Date :
September 15 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 15 2028
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT07157670
Start Date
September 15 2025
End Date
September 15 2028
Last Update
September 5 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.